World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12068
World Ranking
3433
National Ranking
21

Yaniv Sherer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yaniv Sherer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 179 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yaniv Sherer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yaniv Sherer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yaniv Sherer is affiliated with Ben-Gurion University of the Negev in Israel. Their research primarily spans the field of Medicine, with a focus on several subfields including Emergency Medicine, Infectious Diseases, Oncology, Cardiology and Cardiovascular Medicine, and Modeling and Simulation.

The scientist's recent publications cover various aspects of healthcare impacts related to COVID-19 and cardiac events. These works include:

  • Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19 (2021) published in The American Journal of Emergency Medicine
  • Assessment of Predictors for SARS-CoV-2 Antibodies Decline Rate in Health Care Workers after BNT162b2 Vaccination-Results from a Serological Survey (2022) published in Vaccines
  • Challenging Organizational Factors Associated With Admission Delay to Intensive Care Unit-A Novel Quality Indicator (2023) published in Journal of Intensive Care Medicine

Yaniv Sherer's main research topics reflect an emphasis on critical healthcare and infectious disease themes, including:

  • COVID-19 and healthcare impacts
  • Acute Myocardial Infarction Research
  • Cardiac Arrest and Resuscitation
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Emergency and Acute Care Studies

The scientist has published in journals such as The American Journal of Emergency Medicine, Vaccines, and Journal of Intensive Care Medicine, each contributing at least one publication to these venues.

Yaniv Sherer frequently collaborates with other researchers, including Sharon Bruoha, Chaim Yosefy, Enrique Gallego-Colón, Jonathan Rieck, and Yan Orlov, each appearing as coauthors on at least one publication.

Best Publications

  • Autoantibody Explosion in Systemic Lupus Erythematosus: More Than 100 Different Antibodies Found in SLE Patients

    Yaniv Sherer;Alexander Gorstein;Marvin J. Fritzler;Yehuda Shoenfeld

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

    A Doria;Y Shoenfeld;R Wu;P F Gambari

  • Mechanisms of Disease: atherosclerosis in autoimmune diseases

    Yaniv Sherer;Yehuda Shoenfeld;Yehuda Shoenfeld

  • European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

    Marta Mosca;C. Tani;M. Aringer;S. Bombardieri

  • Intravenous immunoglobulin: adverse effects and safe administration.

    Hedi Orbach;Uriel Katz;Yaniv Sherer;Yehuda Shoenfeld

  • Matrix metalloproteinase-9 and autoimmune diseases.

    Maya Ram;Yaniv Sherer;Yehuda Shoenfeld

  • A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.

    Gal Yaniv;Gilad Twig;Gilad Twig;Dana Ben-Ami Shor;Ariel Furer

  • Safety of intravenous immunoglobulin (IVIG) therapy.

    Uriel Katz;Anat Achiron;Anat Achiron;Yaniv Sherer;Yaniv Sherer;Yehuda Shoenfeld;Yehuda Shoenfeld

  • Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report

    O. Barzilai;Y. Sherer;M. Ram;D. Izhaky

  • A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.

    Yair Levy;Yaniv Sherer;Alaa Ahmed;Pnina Langevitz

  • The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

    Yehuda Shoenfeld;Gisele Zandman-Goddard;Ljudmila Stojanovich;Maurizio Cutolo

  • Tobacco smoking and autoimmune rheumatic diseases

    Michal Harel-Meir;Yaniv Sherer;Yehuda Shoenfeld

  • The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

    Yehuda Shoenfeld;Miri Blank;Mahmoud Abu-Shakra;Mahmoud Abu-Shakra;Howard Amital

  • Atherosclerosis as an infectious, inflammatory and autoimmune disease

    Yehuda Shoenfeld;Yaniv Sherer;Dror Harats

  • Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

    Ricard Cervera

  • In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases*

    I. Krause;R. Wu;Y. Sherer;M. Patanik

  • The mosaic of autoimmunity: Genetic factors involved in autoimmune diseases - 2008

    Yehuda Shoenfeld;Boris Gilburd;Mahmud Abu-Shakra;Howard Amital

  • Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis.

    R Gerli;E Bartoloni Bocci;Y Sherer;G Vaudo

  • The pathogenic role of anti‐thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice

    Shelly Tartakover Matalon;Miri Blank;Yair Levy;Howard J.A. Carp

Frequent Co-Authors

Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Pnina Langevitz
Pnina Langevitz Tel Aviv University
Miri Blank
Miri Blank Tel Aviv University
Dror Harats
Dror Harats Sheba Medical Center
Boris Gilburd
Boris Gilburd Sheba Medical Center
Gisele Zandman-Goddard
Gisele Zandman-Goddard Wolfson Medical Center
Howard Amital
Howard Amital Sheba Medical Center
Roberto Gerli
Roberto Gerli University of Perugia
Nicola Bizzaro
Nicola Bizzaro University of Genoa
Andrea Doria
Andrea Doria University of Padua

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA often aligns with advanced healthcare roles, such as nursing and nurse practitioner positions. Many professionals choose to enhance their expertise through specialized certifications and degree programs that offer flexibility and accelerated paths. For instance, an doctorate in nursing salary varies by state but typically reflects the investment in higher education and specialization in fields related to immunological health.

Transitioning from general nursing roles to specialized ones, like acute care, frequently requires additional qualifications. Gaining an acute care nurse practitioner certification can open doors in hospital settings and critical care, both of which are closely related to immunology studies.

For those seeking to fast-track their nursing careers, exploring a nurse practitioner accelerated program offers an efficient route to advanced practice roles that intersect with immunology and patient care.

Additionally, individuals without a nursing background can enter the field by enrolling in online ADN programs for non nurses. These programs provide foundational knowledge that supports further specialization in immunology or related clinical careers.

Best Scientists Citing Yaniv Sherer

Trending Scientists

Recently Published Articles